Overview

SMi presents the 7th annual conference…
Advances in Cell Based Assays
11th-12th November 2014
Marriott Regents Park Hotel
http://www.smi-online.co.uk/goto/2014cellbasedassay7.asp

SMi Group invites you to attend the market leading cell based event, Advances in Cell Based Assays, taking place on 11th & 12th November in Central London.

We have worked closely with an array of industry KOLs and scientific leaders to host a packed conference agenda for the 7th annual conference this autumn

Expand your scientific horizons as we ask the questions:

• How have recent advances in high throughput sample expression techniques opened up new possibilities for primary HTS within the biologics industry?
• What are the current challenges of bioassay method development and how can we validate these with reference to cell based assays and regulatory guidelines in drug development?
• What is the next generation of target identification and screening technologies?
• How easy is it to use adult stem cells in therapeutic applications, in vitro and in vivo paradigm?
• How can we exploit gene editing in human cell lines to provide novel, isogenic assays?
• How are new technologies impacting the industry?
• 3D cell culture, how can this be used in oncology research?
• What is the next generation of cell based assays?


Key Speakers Include:

• Steve Ludbrook, Group Leader, Biological Sciences UK, RD Platform Technology & Science, GSK
• Beverley Isherwood, Team Leader High Content Biology, Innovative Medicines, AstraZeneca R&D
• Dr Lesley Jenkinson, Scientist 1, Medimmune
• Dr Farnaz Fallah-Arani, Group Leader, Pharmacology, UCB
• Neil Carragher, PhD, Principal Investigator Drug Discovery, Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh
• Niclas Nilsson, Head of Section, Lead Discovery, LEO Pharma
• Dr Christa Burger, Principal Scientist, Cellular Pharmacology, Merck Serono
• Dr Marianne Uteng, PhD, Head of Cellular Models & HCB Laboratory, Discovery and Investigative Safety (DIS), Novartis
• Anker Jon Hansen, Principal Scientist, Novo Nordisk
• Daniel Nolan, Director of Research, Angiocrine Bioscience


For further details and to download a copy of the PDF, visit http://www.smi-online.co.uk/goto/2014cellbasedassay7.asp

Alternatively contact Fateja Begum on +44 (0)20 7827 6184 or email fbegum@smi-online.co.uk



Venue: Marriott Hotel Regents Park
Location: London
Country: United Kingdom

Organiser Contact Details:
SMi Group Ltd
T: +44 (0)20 7827 6184
fbegum@smi-online.co.uk